Structure–activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation
Authors:
- Wei-Jern TsaiWTWei-Jern Tsai
- Keduo QianKQKeduo Qian
- Kuo-Hsiung LeeKLKuo-Hsiung Lee
- Tian-Shung WuTWTian-Shung Wu
- 1 December 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (24) , 7711-7719
Abstract
No abstract availableKeywords
Funding Information
- National Science Council, Taiwan, Republic of China (OUA 95-3-2-021)
- Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004)
This publication has 19 references indexed in Scilit:
- Anticancer activities of novel chalcone and bis-chalcone derivativesBioorganic & Medicinal Chemistry, 2006
- Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activitiesBioorganic & Medicinal Chemistry Letters, 2004
- Antimycobacterial and antioxidant flavones fromLimnophila geoffrayiArchives of Pharmacal Research, 2003
- Novel Platelet InhibitorsAnnual Review of Medicine, 2001
- Antiplatelet DrugsDrugs, 1995
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- Thromboxane A2: Its generation and role in platelet activationProgress in Lipid Research, 1989
- Antithrombotic Therapy in Peripheral Vascular DiseaseChest, 1986
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985